Charles M. Baum
2012
In 2012, Charles M. Baum earned a total compensation of $1.4M as President and Chief Executive Officer at Mirati Therapeutics.
Compensation breakdown
| Option Awards | $1,309,824 |
|---|---|
| Salary | $135,438 |
| Total | $1,445,262 |
Baum received $1.3M in option awards, accounting for 91% of the total pay in 2012.
Baum also received $135.4K in salary.
Rankings
In 2012, Charles M. Baum's compensation ranked 4,699th out of 11,487 executives tracked by ExecPay. In other words, Baum earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,699 out of 11,487 | 59th |
Division Manufacturing | 1,639 out of 4,253 | 62nd |
Major group Chemicals And Allied Products | 377 out of 1,198 | 69th |
Industry group Drugs | 237 out of 920 | 74th |
Industry Pharmaceutical Preparations | 185 out of 700 | 74th |
Source: SEC filing on April 17, 2014.